IL247290A0 - שיטות לטיפול או מניעה של אסטמה על ידי הוספה של אנטגוניסט של il–4r - Google Patents
שיטות לטיפול או מניעה של אסטמה על ידי הוספה של אנטגוניסט של il–4rInfo
- Publication number
- IL247290A0 IL247290A0 IL247290A IL24729016A IL247290A0 IL 247290 A0 IL247290 A0 IL 247290A0 IL 247290 A IL247290 A IL 247290A IL 24729016 A IL24729016 A IL 24729016A IL 247290 A0 IL247290 A0 IL 247290A0
- Authority
- IL
- Israel
- Prior art keywords
- antagonist
- administering
- treating
- methods
- preventing asthma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461943019P | 2014-02-21 | 2014-02-21 | |
EP14306413 | 2014-09-15 | ||
US201462077669P | 2014-11-10 | 2014-11-10 | |
PCT/US2015/016852 WO2015127229A1 (en) | 2014-02-21 | 2015-02-20 | Methods for treating or preventing asthma by administering an il-4r antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
IL247290A0 true IL247290A0 (he) | 2016-09-29 |
IL247290B IL247290B (he) | 2021-06-30 |
Family
ID=66624883
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL247290A IL247290B (he) | 2014-02-21 | 2016-08-16 | שיטות לטיפול או מניעה של אסטמה על ידי הוספה של אנטגוניסט של il–4r |
IL283422A IL283422A (he) | 2014-02-21 | 2021-05-25 | שיטות לטיפול או מניעה של אסטמה על ידי הוספה של אנטגוניסט של il-4r |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL283422A IL283422A (he) | 2014-02-21 | 2021-05-25 | שיטות לטיפול או מניעה של אסטמה על ידי הוספה של אנטגוניסט של il-4r |
Country Status (2)
Country | Link |
---|---|
JP (2) | JP6893265B2 (he) |
IL (2) | IL247290B (he) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
CN104039352A (zh) | 2011-11-01 | 2014-09-10 | 米迪缪尼有限公司 | 用于降低哮喘急性恶化的频率和严重性的方法 |
SG11201500889TA (en) * | 2012-08-21 | 2015-03-30 | Sanofi Sa | Methods for treating or preventing asthma by administering an il-4r antagonist |
-
2016
- 2016-08-16 IL IL247290A patent/IL247290B/he active IP Right Grant
-
2020
- 2020-03-04 JP JP2020036331A patent/JP6893265B2/ja active Active
-
2021
- 2021-05-25 IL IL283422A patent/IL283422A/he unknown
- 2021-05-28 JP JP2021089717A patent/JP7343547B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2021130695A (ja) | 2021-09-09 |
IL247290B (he) | 2021-06-30 |
JP6893265B2 (ja) | 2021-06-23 |
IL283422A (he) | 2021-06-30 |
JP7343547B2 (ja) | 2023-09-12 |
JP2020105193A (ja) | 2020-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274134A (he) | שיטות לטיפול או מניעת אסטמה על ידי מתן אגוניסט ל- il-4r | |
PL3107575T3 (pl) | Sposoby leczenia lub zapobiegania astmie przez podawanie antagonisty IL-4R | |
PT3506931T (pt) | Métodos de prevenção ou de tratamento da alergia mediante a administração de um antagonista de il-4r | |
HRP20181963T1 (hr) | Postupci za liječenje ili sprječavanje astme primjenom antagonista il-4r | |
HK1246714A1 (zh) | 用於神經調節的裝置和方法 | |
IL279627A (he) | שיטה לטיפול בדיכאון | |
PT3110848T (pt) | Métodos para tratamento de infeção cutânea por administração de um antagonista do il-4r | |
SG11201703980YA (en) | Respiratory gas therapy | |
GB201404942D0 (en) | An inhaler | |
GB201404940D0 (en) | An inhaler | |
ZA201700416B (en) | Methods for treating or preventing ophthalmological conditions | |
SG11201609350XA (en) | Methods for inhibiting necroptosis | |
HK1215864A1 (zh) | 用於埋線療法的套管 | |
GB2528068B (en) | An inhaler | |
HK1246206A1 (zh) | 用於治療青光眼的組合物和方法 | |
HK1223837A1 (zh) | 減少過劑量的組合物和方法 | |
SG11201700059WA (en) | Therapeutic agent for keratoconjunctive disorder | |
GB201409603D0 (en) | An inhalable medicament | |
IL247290A0 (he) | שיטות לטיפול או מניעה של אסטמה על ידי הוספה של אנטגוניסט של il–4r | |
GB201401806D0 (en) | Novel methods for diagnosis and therapy | |
IL271284A (he) | שיטות לטיפול או מניעה של אסטמה באמצעות מתן של אנאטגוניסט ל–il–r4 | |
PT3703818T (pt) | Antagonista de il-4r para utilização num método para o tratamento ou prevenção de asma | |
IL246913A0 (he) | שיטות לטיפול בדלקת עור על ידי מתן אנטגוניסט ל–il–4r | |
HU4417U (en) | Construction for stabilize rails | |
SG10201400823PA (en) | Therapeutic methods and compositions for treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted |